Back to search

United Kingdom· GB-APID-41150811000001105

Hepcludex 2mg powder for solution for injection vials

A bulevirtide product containing bulevirtide, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC J05AX28

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedHepcludex 2mg powder for solution for…ATCJ05AX28REGISTER NO.GB-APID-4115081100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Bulevirtide is registered in 14 of 19 countries.

Countries holding a registration under ATC J05AX28 (bulevirtide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Bulevirtide · ATC J05AX28

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bulevirtide costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bulevirtide · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$219.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Bulevirtide
Manufacturer
Gilead Sciences Ltd
Country
United Kingdom (GB)
ATC code
J05AX28
ATC class
Bulevirtide
Defined daily dose
2 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    05391507147110
  • gtin
    05391507147196

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd32aa5a-988a-4652-96e3-b550f925f1aa
GET /v1/drugs/fd32aa5a-988a-4652-96e3-b550f925f1aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "41150811000001105",
  "desc": "Hepcludex 2mg powder for solution for injection vials (Gilead Sciences Ltd)",
  "form": "Powder for solution for injection",
  "vpid": "41151611000001101",
  "source": "dmd",
  "vtm_id": "41151411000001104",
  "strength": "2 mg",
  "substance": "Bulevirtide",
  "ingredient": "Bulevirtide acetate",
  "supplier_code": "2572301000001107"
}

See everything about bulevirtide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.